Skip to main content
. 2021 Dec 16;8:725532. doi: 10.3389/fcvm.2021.725532

Figure 2.

Figure 2

The molecular mechanisms interactome in the pathophysiology of diabetic cardiomyopathy (DbCM). AGEs, advanced glycation end products; LV, left ventricle; ROS, reactive oxygen species.